King Pharmaceuticals (NYSE: KG), was the world's 39th largest pharmaceutical company, based in Bristol, Tennessee. However, on October 12, 2010, King was acquired by Pfizer for $14.25 per share. King produced a wide range of pharmaceuticals, including Altace for heart attack prevention, Levoxyl for hypothyroidism, Sonata, a sleeping aid, and Skelaxin, a muscle relaxant. King Pharmaceuticals operated manufacturing facilities in Bristol, Tennessee, Rochester, Michigan, St. Louis, Missouri, St. Petersburg, Florida, and Middleton, Wisconsin, and they employed approximately 2,700 people including a sales force of over 1,000 individuals.
King's wholly owned subsidiaries were Monarch Pharmaceuticals, Inc., King Pharmaceutical Research and Development, Inc., Meridian Medical Technologies Inc., Parkdale Pharmaceuticals, Inc., King Pharmaceuticals of Nevada, Inc., and Monarch Pharmaceuticals Ireland Limited.
Read more about King Pharmaceuticals: Company History, King Pharmaceuticals Acquiring U.S. Marketing and Distribution Rights To Altace, Acquisition
Famous quotes containing the word king:
“If the king is in the palace, nobody looks at the walls. It is when he is gone, and the house is filled with grooms and gazers, that we turn from the people, to find relief in the majestic men that are suggested by the pictures and the architecture.”
—Ralph Waldo Emerson (1803–1882)